TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Canadian Pot Stocks Get Hit Hard: Is it Time to Invest?
Investing
3 Things Investors Should Watch for in Aphria Inc.’s Q3 Results

Investing
Will Canadian Pot Stocks Still Beat the Market This Year?

Investing
Marijuana Legalization Is Coming! Why Canopy Growth Corp. Could Go Parabolic

Investing
Have Canadian Cannabis Stocks Reached Their Peak?

Investing
Thinking of Investing in Pot Stocks? Here’s Why You Should Buy Today
Investing
Could Canadian Marijuana Stocks Recover to Beat the TSX This Year?
Investing
Here’s My Prediction for Cannabis Stocks Before and After Legalization Day

Investing
Are Pot Stocks Drying Up?

Investing
Marijuana Stocks: Is the Recent Dip a Buying Opportunity?

Investing
Why Canopy Growth Corp. Has Been More Resilient This Time Around
